BLFS News and Press, BioLife Solutions Inc.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options a...

                  Fast-tracks Repligen’s leadership and customer solution offering in high-growth cell therapy market by adding BioLife’s differentiated, high-margin recurring revenue business BioLife stockholders to receive cash and...

2026-07-01 09:35:38 ET More on the Markets S&P 500 Risks Bull Trap As Stronger U.S. Dollar Threatens Q2 Rally The Symbios Thesis: How I View The Second Winner Of The AI Boom Halftime Show: Expect A Historic 2nd Half Of 2026. Plus The Latest On My Personal Portfol...

2026-06-27 12:20:23 ET More on BioLife Solutions, Repligen Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript Repli...

2026-05-08 10:21:18 ET Image source: The Motley Fool. Thursday, May 7, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-05-08 02:12:26 ET More on BioLife Solutions BioLife Solutions, Inc. (BLFS) Q1 2026 Earnings Call Transcript BioLife Looks Strong For Fiscal Year 2026 BioLife Solutions, Inc. (BLFS) Q4 2025 Earnings Call Transcript BioLife Solutions GAAP EPS of $0.02 beat...

2026-05-08 02:11:18 ET BioLife Solutions, Inc. (BLFS) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDT Company Participants Troy Wichterman - Chief Financial Officer Roderick de Greef - CEO & Chairman Conference Call Participants Matthew Stanton - Jeff...

2026-05-07 16:58:52 ET More on BioLife Solutions BioLife Looks Strong For Fiscal Year 2026 BioLife Solutions, Inc. (BLFS) Q4 2025 Earnings Call Transcript BioLife Solutions Q1 2026 Earnings Preview BioLife Solutions outlines 17–20% revenue growth targe...

BioLife Solutions Reports First Quarter 2026 Financial Results PR Newswire Total revenue of $27.5 million, up 25% over Q1 2025 GAAP gross margin and non-GAAP adjusted gross margin of 64% GAAP net income of $1.2 million and non-GAAP adjusted EBITDA of $6.2 million or 22% o...

BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026 PR Newswire BOTHELL, Wash. , April 23, 2026 /PRNewswire/ -- BioLife Solutions, Inc.  (NASDAQ: BLFS ), a leading developer and supplier of bioproduction products and services...